Universidad Complutense de Madrid. Facultad de Medicina. Departamento de Farmacología y Toxicología
Tamargo J. Moderador. Expert Session: "Safety first: avoiding adverse events with new cardiovacular drugs". Ponente "Safey first: avoiding adverse events with new cardiovascular drugas - Take Home Message". Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.
Tamargo J. Ponente "Are regulations for generic CV drugs". Symnposium: "Are generic drugs safe in heart failure?". Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.
Tamargo J. Moderador. Case-based Session "Antithrombotics and cancer: challenges in clinical practice?" Congreso: ESC (European Society of Cardiology) Congress. Munich, 25-29 de agosto de 2018.
|